MaxCyte, Inc. - Form 8-K Filing Summary

MaxCyte, Inc. received a notice from Nasdaq on March 16, 2026, indicating non-compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market due to the closing bid price of its common stock falling below $1.00 for 30 consecutive trading days. However, as of June 10, 2026, the Company has regained compliance. For the period from May 27, 2026, to June 9, 2026, the closing bid price of MaxCyte's common stock has been at or above $1.00 for 10 consecutive business days. Consequently, Nasdaq has determined that the Company has met the minimum bid price requirement, and this matter is now closed.